EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of an MR‐compatible motion platform for quality assurance of motion‐compensated treatments on the 1.5 T MR‐linac

Stijn Oolbekkink iD, Pim T S Borman iD, Jochem W H Wolthaus, Bram van Asselen, Astrid L H M W van Lier iD, Stephanie Dunn, Grant R Koenig, Nick Hartman, Niusha Kheirkhah, Bas W Raaymakers, Martin F Fast iD

Medical Physics · 2025-05 · 52 (5) · 3391-3397

DOI: 10.1002/mp.17632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Physics, online erschienen am 31.01.2025. Verfasst von Stijn Oolbekkink und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Quality Assurance, Health Care, Particle Accelerators. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek, ITEA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Novel motion‐compensated treatment techniques on the MR‐linac can address adverse intra‐fraction motion effects. These techniques involve beam gating or intra‐fraction adaptations of the treatment plan based on real‐time magnetic resonance imaging (MRI) performed during treatment. For quality assurance (QA) of these workflows, a multi‐purpose motion platform is desirable. This platform should accommodate various phantoms, enabling multiple QA workflows.

Purpose

This study aims to evaluate the new IBA QUASAR Motion MR Platform for use in the 1.5 T MR‐linac.

Methods

The motion platform was assessed for several magnetic resonance (MR) characteristics, including spurious noise generation and B0&B1 homogeneity. In addition, the motion platform's motion accuracy and beam attenuation were assessed. An application was shown with a ScandiDos Delta4 Phantom+ MR demonstrating patient‐specific plan QA of gated treatments using time‐resolved dosimetry that includes motion based on a patient's respiratory motion trace.

Results

All MR characterization measurements were within the set tolerances for MRI QA. The motion platform motion accuracy showed excellent agreement with the reference, with a standard deviation of the amplitude of 0.01 mm (20 kg load) for the motor's self‐estimated positions and 0.22 mm (no load) for the images acquired with the electronic portal imager. Beam attenuation was found to be 11.8%. The combination of the motion platform and Delta4 demonstrated motion‐included dosimetry at high temporal and spatial resolutions. Motion influenced the measured dose in non‐gated treatments by up to −20.1%, while gated deliveries showed differences of up to −1.7% for selected diodes.

Conclusion

The motion platform was found to be usable in a 1.5 T magnetic field, and for all MR characterization experiments, no influence from the motion platform was observed. This motion platform enables to perform motion‐included QA, with a measurement device of choice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingQuality Assurance, Health CareParticle AcceleratorsMovementPhantoms, ImagingHumansQuality ControlRadiotherapy Planning, Computer-Assisted

Stichwörter der Autor:innen

MR‐linacmotion‐included dosimetryquality assurance

Autor:innen und Institutionen

  • Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.
  • IBA QUASAR, Modus Medical Devices Inc., London, Ontario, Canada.

ORCID-Profile: Stijn Oolbekkink, Pim T S Borman, Astrid L H M W van Lier, Martin F Fast

Förderung

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • ITEA

Zitieren

APA

Oolbekkink, S., Borman, P. T. S., Wolthaus, J. W. H., van Asselen, B., van Lier, A. L. H. M. W., Dunn, S., Koenig, G. R., Hartman, N., Kheirkhah, N., Raaymakers, B. W., & Fast, M. F. (2025). Characterization of an MR‐compatible motion platform for quality assurance of motion‐compensated treatments on the 1.5 T MR‐linac. Medical Physics, 52(5), 3391-3397. https://doi.org/10.1002/mp.17632

Vancouver

Oolbekkink S, Borman PTS, Wolthaus JWH, van Asselen B, van Lier ALHMW, Dunn S, et al. Characterization of an MR‐compatible motion platform for quality assurance of motion‐compensated treatments on the 1.5 T MR‐linac. Medical Physics. 2025;52(5):3391-3397. doi:10.1002/mp.17632

BibTeX
@article{Oolbekkink2025,
  author = {Oolbekkink, Stijn and Borman, Pim T S and Wolthaus, Jochem W H and van Asselen, Bram and van Lier, Astrid L H M W and Dunn, Stephanie and Koenig, Grant R and Hartman, Nick and Kheirkhah, Niusha and Raaymakers, Bas W and Fast, Martin F},
  title = {Characterization of an MR‐compatible motion platform for quality assurance of motion‐compensated treatments on the 1.5 T MR‐linac},
  journal = {Medical Physics},
  year = {2025},
  volume = {52},
  number = {5},
  pages = {3391--3397},
  doi = {10.1002/mp.17632}
}
Kostenlos starten →